PEPSICO INC Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD from Q4 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Pepsico Inc quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and growth rate from Q4 2015 to Q2 2024.
  • Pepsico Inc Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending June 15, 2024 was $6.42B, a 2.82% increase year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.42B +$176M +2.82% Jun 15, 2024 10-Q 2024-07-11
Q1 2024 $8.13B +$3.29B +68.1% Mar 23, 2024 10-Q 2024-04-23
Q4 2023 $9.76B +$4.66B +91.4% Dec 30, 2023 10-Q 2024-07-11
Q3 2023 $10.1B +$3.61B +55.4% Sep 9, 2023 10-Q 2023-10-10
Q2 2023 $6.24B +$697M +12.6% Jun 17, 2023 10-Q 2024-07-11
Q1 2023 $4.84B -$1.85B -27.7% Mar 25, 2023 10-Q 2024-04-23
Q4 2022 $5.1B -$607M -10.6% Dec 31, 2022 10-Q 2024-07-11
Q3 2022 $6.52B -$89M -1.35% Sep 3, 2022 10-Q 2023-10-10
Q2 2022 $5.55B -$1M -0.02% Jun 11, 2022 10-Q 2023-07-13
Q1 2022 $6.69B +$960M +16.8% Mar 19, 2022 10-Q 2023-04-25
Q4 2021 $5.71B -$2.55B -30.9% Dec 25, 2021 10-K 2024-02-09
Q3 2021 $6.61B -$2.55B -27.9% Sep 4, 2021 10-Q 2022-10-12
Q2 2021 $5.55B -$3.44B -38.3% Jun 12, 2021 10-Q 2022-07-12
Q1 2021 $5.73B -$5.56B -49.2% Mar 20, 2021 10-Q 2022-04-26
Q4 2020 $8.25B +$2.68B +48.2% Dec 26, 2020 10-K 2024-02-09
Q3 2020 $9.16B +$3.45B +60.5% Sep 5, 2020 10-Q 2021-10-05
Q2 2020 $8.99B +$5.52B +159% Jun 13, 2020 10-Q 2021-07-13
Q1 2020 $11.3B +$5.99B +113% Mar 21, 2020 10-Q 2021-04-15
Q4 2019 $5.57B -$5.2B -48.3% Dec 28, 2019 10-K 2023-02-09
Q3 2019 $5.71B -$6.34B -52.6% Sep 7, 2019 10-Q 2020-10-01
Q2 2019 $3.47B -$10.4B -75% Jun 15, 2019 10-Q 2020-07-13
Q1 2019 $5.31B -$8.17B -60.6% Mar 23, 2019 10-Q 2020-04-28
Q4 2018 $10.8B +$112M +1.05% Dec 29, 2018 10-K 2022-02-10
Q3 2018 $12B +$1.76B +17.2% Sep 8, 2018 10-Q 2019-10-03
Q2 2018 $13.9B +$3.59B +34.9% Jun 16, 2018 10-Q 2019-07-09
Q1 2018 $13.5B +$3.93B +41.2% Mar 24, 2018 10-Q 2019-04-17
Q4 2017 $10.7B +$1.49B +16.2% Dec 30, 2017 10-K 2021-02-11
Q3 2017 $10.3B Sep 9, 2017 10-Q 2018-10-02
Q2 2017 $10.3B Jun 17, 2017 10-Q 2018-07-10
Q1 2017 $9.55B Mar 25, 2017 10-Q 2018-04-26
Q4 2016 $9.17B +$50M +0.55% Dec 31, 2016 10-K 2020-02-13
Q4 2015 $9.12B Dec 26, 2015 10-K 2019-02-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.